PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 235 (xsd:integer)
nif:isString
  • Even though current advances in the chemotherapy and molecular targeting therapy for NSCLC, the overall 5-year survival rate for the disease is less than 15% due to the limited therapeutic options, tumor metastasis, and recurrence [4].
rdf:type